InSilico Medicine Cayman TopCo Company Description

InSilico Medicine Cayman TopCo operates as an artificial intelligence (AI)-based biotech company that helps to develop and manufacture novel drugs in Hong Kong, the United States, the United Kingdom, Mainland China, and internationally.

The company develops solutions to discover and develop drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases.

It also offers Pharma.AI platform, a commercially end-to-end generative Al software and automation platform which is designed to enhance the quality and productivity of pharmaceutical research.

The company was founded in 2014 and is based in New Territories, Hong Kong.

InSilico Medicine Cayman TopCo

Country	Cayman Islands
Founded	2014
Industry	Software - Infrastructure
Sector	Technology
Employees	319

Contact Details

Address: Building 8W, Phase 2 Hong Kong Hong Kong
Phone	852 1626 5937 957
Website	insilico.com

Stock Details

Ticker Symbol	3696
Exchange	Hong Kong Stock Exchange
Fiscal Year	January - December
Reporting Currency	USD
SIC Code	7372

Key Executives

Name	Position
Dr. Feng Ren Ph.D.	CO-Chief Executive Officer, Chief Scientific Officer and Executive Director
Dr. Alexander Zhavoronkov Ph.D.	Founder, Chief Executive Officer, Chief Business Officer and Chairman of the Board
Aleksandr Aliper Ph.D.	President
Peng Dai	Vice President and Head of Finance
Dr. Xiao Ding	Head of Chemistry
Dr. Man Zhang	Head of Biology
Leung Kwan Wai	Company Secretary